Anthropic Acquires Startup Coefficient Bio for About $400 Million

Dario Amodei, co-founder and chief executive officer of Anthropic. Photo by David Paul Morris/Getty Images

and

Anthropic has acquired AI biotech startup Coefficient Bio for roughly $400 million, according to a person with knowledge of the deal.

The startup’s team will be joining Anthropic’s healthcare life sciences group, which develops tools for the biotech industry ranging from drug discovery to clinical commercialization, said the person.

Coefficient Bio, which was founded last fall, was developing a platform that enables AI to run biotech tasks such as planning drug research and development, managing clinical regulatory strategy and identifying new drug opportunities. The company’s cofounders include CEO Aris Theologis, who previously held executive roles at life sciences firms Evozyne and Paragon Biosciences, and Chief Technology Officer Nathan Frey, who was a research scientist at Prescient Design and Genentech, according to their LinkedIn profiles. Coefficient Bio has fewer than ten employees, according to the person.